Introduksjon
Denne siden gir en grundig analyse av den kjente historikken for insidernes handelsaktiviteter for David Shapiro. Insidere er ledere, direktører eller betydelige investorer i et selskap. Det er ulovlig for insidere å gjøre handler i deres selskaper basert på spesifikke, ikke-offentlig informasjon. Dette betyr ikke at det er ulovlig for dem å gjøre noen handler i deres egne selskaper. Imidlertid må de rapportere alle handler til SEC via et skjema 4. Til tross for disse begrensningene, antyder akademisk forskning at insidere - generelt sett - har en tendens til å overgå markedet i sine egne selskaper.
Gjennomsnittlig handelslønnsomhet
Den gjennomsnittlige handelslønnsomheten er den gjennomsnittlige avkastningen av alle åpne markedskjøp gjort av insideren de siste tre årene. For å beregne dette, undersøker vi hvert eneste åpne marked, uplanlagte kjøp som er gjort av insideren, men dette inkluderer ikke alle handler som ble markert som en del av en 10b5-1 handelsplan. Vi beregner deretter gjennomsnittlig ytelse av disse handlene over 3, 6 og 12 måneder, gjennomsnittlig hver av disse varighetene for å generere en endelig ytelsesmåling for hver handel. Til slutt,
Dersom lønnsomheten for denne interne handelen er "N/A", har enten den interne personen ikke gjort noen åpen-markeds kjøp de siste tre årene, eller så er handlene for nylig til å beregne en pålitelig prestasjonsmåler.
Oppdateringsfrekvens: Daglig
Selskaper med rapporterte insiderposisjoner
SEC-arkiveringene indikerer at David Shapiro har rapporterte beholdninger av handler i følgende selskaper:
Verdipapir | Navn | Siste rapporterte høydepunkter |
---|---|---|
US:ONVO / Organovo Holdings, Inc. | Director | 52 000 |
US:ICPT / Intercept Pharmaceuticals Inc | Chief Medical Officer | 9 031 |
Hvordan tolke diagrammene
De følgende diagrammene viser aksjens ytelse etter hver åpen markedstransaksjon som ikke var planlagt, utført av David Shapiro. Ikke-planlagte handler er handler som ikke ble gjort som en del av en 10b5-1 handelsplan. Aksjeytelsen er kartlagt som kumulativ prosentendring i aksjekursen. For eksempel, hvis en innsidehandel ble gjort 1. januar 2019, vil diagrammet vise daglig prosentendring for verdipapiret til dagens dato. Dersom aksjeprisen går fra $10 til $15 i løpet av denne tiden, vil den kumulative prosentendringen i aksjeprisen være 50%. En endring i prisen fra $10 til $20 vil være 100%, og en endring i prisen fra $10 til $5 vil være - 50%.
Til syvende og sist er målet vårt å avgjøre hvor tett insidernes handler korrelerer med overavkastninger (positiv eller negativ) i aksjekursen for å se om insidere timer sine handler for å tjene på intern informasjon. Se for deg en situasjon der en insider gjør dette. I denne situasjonen, forventer vi enten (a) positive avkastninger etter kjøp, eller (b) negative avkastninger etter salg. I tilfelle (a) KJØP-diagrammet ville vise en serie av oppadgående kurver, som indikerer positive avkastninger etter hver kjøpstransaksjon. I tilfelle (b) ville SALG-diagrammet vise en serie av nedadgående kurver, som indikerer negative avkastninger etter hver salgstransaksjon.
Imidlertid er dette alene ikke nok til å dra konklusjoner. Hvis, for eksempel, aksjeprisen for selskapet steg jevnt over mange år uten å følge en syklisk trend, ville vi forventet at alle postkjøpsdiagrammer skal ha en stigende trend. På samme måte vil ikke-sykliske nedganger over mange år resultere i nedadgående trend i post-trade diagrammer. Ingen av disse diagrammene ville antyde aktiviteter som insidertrening.
Den sterkeste indikatoren ville vært en situasjon der aksjekursen var ekstremt syklisk, og det var både positive signaler i KJØPSdiagrammet og negative plot i SALGSdiagrammet. Denne situasjonen ville vært sterkt antydende om en insider som timet handler til sin økonomiske fordel.
Internkjøp VIVS / VivoSim Labs, Inc. - Analyse av kortsiktig fortjeneste
I denne seksjonen analyserer vi lønnsomheten av hvert uplanlagt, åpen-marked internsalg som er gjort i VIVS / VivoSim Labs, Inc.. Denne analysen hjelper til å forstå om den interne personen regelmessig genererer unormale avkastninger, og er verdt å følge. Denne analysen gjelder ett år etter hver handel, og resultatene er teoretiske.
Følgende tabell viser de mest nylige åpne markedskjøpene som ikke var en del av en handelsplan.
Handelsdato | Ticker | Innsider | Rapporterte aksjer |
Rapportert pris |
Justerte aksjer |
Justert pris |
Kostpris | Dager til maks |
Pris ved maks |
Maks fortjeneste ($) |
Maks fortjeneste (%) |
---|---|---|---|---|---|---|---|
Det er ingen kjente uplanlagte handler på det åpne markedet for denne insideren og verdipapirkombinasjonen. |
Justert pris er prisen justert for splitt. Justerte aksjer er aksjene justert for splitt.
Internhandel VIVS / VivoSim Labs, Inc. - Analyse av kortsiktig tap
I denne seksjonen analyserer vi unngåelsen av kortsiktig tap for hvert uplanlagt, åpen-marked internsalg som er gjort i VIVS / VivoSim Labs, Inc.. Et jevnt mønster av tap unngåelse kan antyde at fremtidige salgstransaksjoner kan forutsi nedgang i pris. Denne analysen gjelder ett år etter hver handel, og resultatene er teoretiske.
Følgende tabell viser de mest nylige åpne markedskjøpene som ikke var en del av en handelsplan.
Handelsdato | Ticker | Innsider | Rapporterte aksjer |
Rapportert pris |
Justerte aksjer |
Justert pris |
Kostpris | Dager til min |
Pris ved min |
Maks tap unngått ($) |
Maks tap unngått (%) |
---|---|---|---|---|---|---|---|
Det er ingen kjente uplanlagte handler på det åpne markedet for denne insideren og verdipapirkombinasjonen. |
Justert pris er prisen justert for splitt. Justerte aksjer er aksjene justert for splitt.
Innsidernes handelshistorikk
Tabellen viser den komplette listen over innsidehandler gjort av David Shapiro som avslørt til Securies Exchange Comission (SEC).
Fildato | Transaksjonsdato | Skjema | Ticker | Verdipapir | Kode | Aksjer | Gjenværende aksjer | Prosent endring |
Aksje pris |
Transaksjons verdi |
Gjenværende verdi |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2019-09-09 |
|
4 | ONVO |
ORGANOVO HOLDINGS, INC.
Stock Option (Right to Buy) |
A - Award | 52 000 | 52 000 | |||||
2019-05-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock |
M - Exercise | X | −2 000 | 9 031 | −18,13 | |||
2019-05-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −2 000 | 39 499 | −4,82 | 86,28 | −172 560 | 3 407 974 |
2019-05-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | X | 2 000 | 41 499 | 5,06 | 31,90 | 63 800 | 1 323 818 |
2019-04-16 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock |
M - Exercise | X | −2 000 | 11 031 | −15,35 | |||
2019-04-16 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −2 000 | 39 499 | −4,82 | 95,00 | −190 000 | 3 752 405 |
2019-04-16 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | X | 2 000 | 41 499 | 5,06 | 31,90 | 63 800 | 1 323 818 |
2019-04-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −562 | 39 499 | −1,40 | 115,01 | −64 636 | 4 542 780 |
2019-04-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
F - Taxes | −482 | 40 061 | −1,19 | 111,50 | −53 743 | 4 466 802 | |
2019-03-01 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock |
M - Exercise | X | −2 000 | 13 031 | −13,31 | |||
2019-03-01 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −2 000 | 40 543 | −4,70 | 103,16 | −206 320 | 4 182 416 |
2019-03-01 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | X | 2 000 | 42 543 | 4,93 | 31,90 | 63 800 | 1 357 122 |
2019-02-20 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock |
M - Exercise | X | −2 000 | 15 031 | −11,74 | |||
2019-02-20 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −2 000 | 40 543 | −4,70 | 111,51 | −223 020 | 4 520 950 |
2019-02-20 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | X | 2 000 | 42 543 | 4,93 | 31,90 | 63 800 | 1 357 122 |
2019-01-18 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock |
A - Award | 5 300 | 5 300 | |||||
2019-01-18 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
A - Award | 3 300 | 40 543 | 8,86 | ||||
2019-01-04 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −474 | 37 243 | −1,26 | 97,48 | −46 206 | 3 630 448 |
2019-01-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −699 | 37 717 | −1,82 | 97,45 | −68 118 | 3 675 522 |
2019-01-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock |
M - Exercise | X | −2 000 | 17 031 | −10,51 | |||
2019-01-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −2 000 | 38 416 | −4,95 | 98,28 | −196 560 | 3 775 524 |
2019-01-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | X | 2 000 | 40 416 | 5,21 | 31,90 | 63 800 | 1 289 270 |
2019-01-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
F - Taxes | −736 | 38 416 | −1,88 | 100,79 | −74 181 | 3 871 949 | |
2018-12-19 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock |
M - Exercise | X | −2 000 | 19 031 | −9,51 | |||
2018-12-19 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −2 000 | 39 152 | −4,86 | 106,62 | −213 240 | 4 174 386 |
2018-12-19 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | X | 2 000 | 41 152 | 5,11 | 31,90 | 63 800 | 1 312 749 |
2018-12-06 |
|
4 | ONVO |
ORGANOVO HOLDINGS, INC.
Stock Option (Right to Buy) |
A - Award | 30 000 | 30 000 | |||||
2018-12-06 |
|
4 | ONVO |
ORGANOVO HOLDINGS, INC.
Stock Option (Right to Buy) |
A - Award | 46 500 | 46 500 | |||||
2018-11-02 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock |
M - Exercise | X | −2 000 | 361 | −84,71 | |||
2018-11-02 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −2 000 | 39 152 | −4,86 | 96,32 | −192 640 | 3 771 121 |
2018-11-02 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | X | 2 000 | 41 152 | 5,11 | 21,50 | 43 000 | 884 768 |
2018-10-16 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock |
M - Exercise | X | −3 425 | 2 361 | −59,19 | |||
2018-10-16 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −3 425 | 39 152 | −8,04 | 102,95 | −352 604 | 4 030 698 |
2018-10-16 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | X | 3 425 | 42 577 | 8,75 | 21,50 | 73 638 | 915 406 |
2018-10-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −759 | 39 152 | −1,90 | 110,65 | −83 983 | 4 332 169 |
2018-10-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
F - Taxes | −426 | 39 911 | −1,06 | 126,46 | −53 872 | 5 047 145 | |
2018-10-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
F - Taxes | −416 | 39 911 | −1,03 | 83,91 | −34 907 | 3 348 932 | |
2018-10-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
F - Taxes | −423 | 39 911 | −1,05 | 61,52 | −26 023 | 2 455 325 | |
2018-10-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
F - Taxes | −1 020 | 39 911 | −2,49 | 58,42 | −59 588 | 2 331 601 | |
2018-09-07 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
S - Sale | −4 917 | 42 196 | −10,44 | 111,43 | −547 891 | 4 701 816 | |
2018-02-22 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Option to Purchase Common Stock |
A - Award | 4 400 | 4 400 | |||||
2018-02-22 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
A - Award | 2 900 | 47 113 | 6,56 | ||||
2017-10-04 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | −349 | 44 213 | −0,78 | 58,90 | −20 556 | 2 604 071 | |
2017-09-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Option to Purchase Common Stock |
M - Exercise | −1 250 | 21 031 | −5,61 | ||||
2017-09-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 250 | 44 562 | −2,73 | 117,43 | −146 788 | 5 232 916 |
2017-09-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 1 250 | 45 812 | 2,81 | 31,90 | 39 875 | 1 461 403 |
2017-08-02 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Option to Purchase Common Stock |
M - Exercise | −1 118 | 0 | −100,00 | ||||
2017-08-02 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 118 | 44 562 | −2,45 | 119,00 | −133 042 | 5 302 878 |
2017-08-02 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 1 118 | 45 680 | 2,51 | 8,67 | 9 689 | 395 895 |
2017-07-13 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −553 | 44 562 | −1,23 | 124,01 | −68 578 | 5 526 134 |
2017-07-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | −100 | 45 115 | −0,22 | 121,35 | −12 135 | 5 474 705 | |
2017-07-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | −250 | 45 215 | −0,55 | 121,20 | −30 300 | 5 480 058 | |
2017-05-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Option to Purchase Common Stock |
M - Exercise | −1 117 | 1 118 | −49,98 | ||||
2017-05-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 117 | 45 465 | −2,40 | 112,18 | −125 305 | 5 100 264 |
2017-05-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 1 117 | 46 582 | 2,46 | 8,67 | 9 681 | 403 712 |
2017-04-11 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −558 | 45 465 | −1,21 | 108,51 | −60 549 | 4 933 407 |
2017-04-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | −346 | 46 023 | −0,75 | 115,00 | −39 789 | 5 292 521 | |
2017-03-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Option to Purchase Common Stock |
M - Exercise | −1 350 | 5 786 | −18,92 | ||||
2017-03-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 350 | 46 369 | −2,83 | 128,66 | −173 691 | 5 965 836 |
2017-03-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 1 350 | 47 719 | 2,91 | 21,50 | 29 025 | 1 025 958 |
2017-02-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Option to Purchase Common Stock |
A - Award | 10 000 | 10 000 | |||||
2017-02-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
A - Award | 6 000 | 46 369 | 14,86 | ||||
2017-01-11 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 565 | 40 369 | −3,73 | 106,01 | −165 906 | 4 279 518 |
2017-01-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | −988 | 41 934 | −2,30 | 103,92 | −102 672 | 4 357 744 | |
2016-12-06 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 350 | 42 922 | −3,05 | 99,75 | −134 662 | 4 281 470 |
2016-10-12 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −411 | 44 272 | −0,92 | 153,34 | −63 023 | 6 788 668 |
2016-10-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Option to Purchase Common Stock |
M - Exercise | X | −1 350 | 8 486 | −13,73 | |||
2016-10-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | −163 | 44 683 | −0,36 | 163,20 | −26 602 | 7 292 252 | |
2016-10-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 350 | 44 846 | −2,92 | 163,06 | −220 131 | 7 312 589 |
2016-10-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 1 350 | 46 196 | 3,01 | 21,50 | 29 025 | 993 214 |
2016-09-28 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −886 | 44 846 | −1,94 | 166,03 | −147 103 | 7 445 781 |
2016-09-28 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 659 | 45 732 | −5,49 | 164,76 | −438 097 | 7 534 809 |
2016-07-07 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | −163 | 48 391 | −0,34 | 145,11 | −23 653 | 7 021 979 | |
2016-04-06 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | −165 | 48 546 | −0,34 | 130,76 | −21 575 | 6 347 875 | |
2016-02-12 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Option to Purchase Common Stock |
A - Award | 10 200 | 10 200 | |||||
2016-02-12 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
A - Award | 7 800 | 48 711 | 19,07 | ||||
2016-01-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | −496 | 40 911 | −1,20 | 145,90 | −72 368 | 5 969 066 | |
2016-01-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | −37 | 41 407 | −0,09 | 145,90 | −5 398 | 6 041 435 | |
2016-01-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −1 623 | 0 | −100,00 | ||||
2016-01-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1 623 | 41 444 | 4,08 | ||||
2015-12-22 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Option to Purchase Common Stock |
M - Exercise | −219 | 22 281 | −0,97 | ||||
2015-12-22 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Option to Purchase Common Stock |
M - Exercise | −7 471 | 9 836 | −43,17 | ||||
2015-12-22 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Option to Purchase Common Stock |
M - Exercise | −3 736 | 2 235 | −62,57 | ||||
2015-12-22 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | 219 | 39 821 | 0,55 | 31,90 | 6 986 | 1 270 290 | |
2015-12-22 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | 7 471 | 39 602 | 23,25 | 21,50 | 160 626 | 851 443 | |
2015-12-22 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | 3 736 | 32 131 | 13,16 | 8,67 | 32 379 | 278 470 | |
2015-12-17 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Option to Purchase Common Stock |
M - Exercise | X | −3 500 | 0 | −100,00 | |||
2015-12-17 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 000 | 28 395 | −3,40 | 157,45 | −157 450 | 4 470 793 |
2015-12-17 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 500 | 29 395 | −7,84 | 157,38 | −393 450 | 4 626 188 |
2015-12-17 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 3 500 | 31 895 | 12,33 | 8,67 | 30 333 | 276 424 |
2015-11-18 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Option to Purchase Common Stock |
M - Exercise | X | −3 500 | 3 500 | −50,00 | |||
2015-11-18 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 500 | 28 395 | −5,02 | 179,49 | −269 235 | 5 096 619 |
2015-11-18 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 764 | 29 895 | −8,46 | 178,00 | −492 002 | 5 321 421 |
2015-11-18 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 3 500 | 32 659 | 12,00 | 8,67 | 30 333 | 283 046 |
2015-11-12 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Option to Purchase Common Stock |
M - Exercise | X | −3 500 | 7 000 | −33,33 | |||
2015-11-12 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −3 500 | 29 159 | −10,72 | 204,15 | −714 525 | 5 952 810 |
2015-11-12 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 3 500 | 32 659 | 12,00 | 8,67 | 30 333 | 283 046 |
2015-10-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −858 | 29 159 | −2,86 | 159,04 | −136 456 | 4 637 427 |
2015-10-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Restricted Stock Unit |
M - Exercise | −1 622 | 1 623 | −49,98 | ||||
2015-10-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Option to Purchase Common Stock |
A - Award | 13 100 | 13 100 | |||||
2015-10-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −282 | 30 017 | −0,93 | 163,39 | −46 076 | 4 904 478 |
2015-10-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1 622 | 30 299 | 5,66 | ||||
2015-10-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
A - Award | 5 150 | 28 677 | 21,89 | ||||
2015-09-17 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Option to Purchase Common Stock |
M - Exercise | X | −5 294 | 10 500 | −33,52 | |||
2015-09-17 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Option to Purchase Common Stock |
M - Exercise | X | −3 500 | 15 794 | −18,14 | |||
2015-09-17 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 500 | 23 527 | −5,99 | 192,85 | −289 275 | 4 537 182 |
2015-09-17 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 000 | 25 027 | −3,84 | 191,04 | −191 044 | 4 781 263 |
2015-09-17 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 000 | 26 027 | −3,70 | 189,16 | −189 161 | 4 923 296 |
2015-09-17 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 5 294 | 27 027 | 24,36 | 8,67 | 45 882 | 234 235 |
2015-09-17 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 3 500 | 21 733 | 19,20 | 8,67 | 30 333 | 188 353 |
2015-08-19 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Option to Purchase Common Stock |
M - Exercise | X | −3 500 | 19 294 | −15,35 | |||
2015-08-19 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −4 272 | 18 233 | −18,98 | 209,37 | −894 429 | 3 817 443 |
2015-08-19 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 3 500 | 22 505 | 18,42 | 8,67 | 30 333 | 195 044 |
2015-07-07 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −41 | 19 005 | −0,22 | 239,00 | −9 799 | 4 542 197 |
2015-07-07 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −9 | 19 046 | −0,05 | 238,16 | −2 143 | 4 535 997 |
2015-07-07 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −801 | 19 055 | −4,03 | 236,13 | −189 140 | 4 499 457 |
2015-07-07 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −1 623 | 3 245 | −33,34 | ||||
2015-07-07 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1 623 | 19 856 | 8,90 | ||||
2015-07-06 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Option to Purchase Common Stock |
M - Exercise | X | −3 500 | 22 794 | −13,31 | |||
2015-07-06 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −100 | 18 233 | −0,55 | 241,81 | −24 181 | 4 408 922 |
2015-07-06 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −381 | 18 333 | −2,04 | 240,59 | −91 664 | 4 410 722 |
2015-07-06 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −398 | 18 714 | −2,08 | 239,32 | −95 251 | 4 478 702 |
2015-07-06 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 902 | 19 112 | −9,05 | 238,51 | −453 641 | 4 558 357 |
2015-07-06 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 000 | 21 014 | −4,54 | 237,64 | −237 640 | 4 993 763 |
2015-07-06 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 3 500 | 22 014 | 18,90 | 8,67 | 30 333 | 190 789 |
2015-06-17 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Option to Purchase Common Stock |
M - Exercise | X | −3 500 | 26 294 | −11,75 | |||
2015-06-17 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 900 | 18 514 | −9,31 | 242,05 | −459 896 | 4 481 323 |
2015-06-17 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 600 | 20 414 | −7,27 | 241,03 | −385 650 | 4 920 413 |
2015-06-17 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 3 500 | 22 014 | 18,90 | 8,67 | 30 333 | 190 789 |
2015-05-19 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Option to Purchase Common Stock |
M - Exercise | X | −3 500 | 29 794 | −10,51 | |||
2015-05-19 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 984 | 18 514 | −9,68 | 307,60 | −610 274 | 5 694 866 |
2015-05-19 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 295 | 20 498 | −10,07 | 306,31 | −702 970 | 6 278 644 |
2015-05-19 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 3 500 | 22 793 | 18,14 | 8,67 | 30 333 | 197 540 |
2015-04-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −843 | 19 293 | −4,19 | 277,70 | −234 102 | 5 357 678 |
2015-04-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Option to Purchase Common Stock |
M - Exercise | X | −2 131 | 33 294 | −6,02 | |||
2015-04-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock |
M - Exercise | X | −203 | 0 | −100,00 | |||
2015-04-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −1 622 | 4 868 | −24,99 | ||||
2015-04-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 000 | 20 136 | −4,73 | 281,15 | −281 150 | 5 661 236 |
2015-04-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −282 | 21 136 | −1,32 | 272,69 | −76 897 | 5 763 483 |
2015-04-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 334 | 21 418 | −5,86 | 269,83 | −359 953 | 5 779 215 |
2015-04-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 2 131 | 22 752 | 10,33 | 8,67 | 18 469 | 197 185 |
2015-04-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 203 | 20 621 | 0,99 | 10,40 | 2 111 | 214 460 |
2015-04-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1 622 | 20 418 | 8,63 | ||||
2015-03-18 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Option to Purchase Common Stock |
M - Exercise | X | −3 500 | 203 | −94,52 | |||
2015-03-18 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 500 | 18 796 | −11,74 | 288,26 | −720 640 | 5 418 062 |
2015-03-18 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 000 | 21 296 | −4,49 | 283,50 | −283 500 | 6 037 416 |
2015-03-18 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 3 500 | 22 296 | 18,62 | 10,40 | 36 400 | 231 881 |
2015-03-16 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Option to Purchase Common Stock |
M - Exercise | X | −5 000 | 5 971 | −45,57 | |||
2015-03-16 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −5 000 | 18 796 | −21,01 | 285,99 | −1 429 938 | 5 375 421 |
2015-03-16 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 5 000 | 23 796 | 26,60 | 8,67 | 43 334 | 206 233 |
2015-02-19 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Option to Purchase Common Stock |
M - Exercise | X | −5 294 | 35 425 | −13,00 | |||
2015-02-19 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Option to Purchase Common Stock |
M - Exercise | X | −3 500 | 3 703 | −48,59 | |||
2015-02-19 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 000 | 18 796 | −9,62 | 212,12 | −424 242 | 3 987 026 |
2015-02-19 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 146 | 20 796 | −5,22 | 210,95 | −241 749 | 4 386 918 |
2015-02-19 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 500 | 21 942 | −6,40 | 204,62 | −306 930 | 4 489 772 |
2015-02-19 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 3 500 | 23 442 | 17,55 | 10,40 | 36 400 | 243 799 |
2015-02-19 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 5 294 | 19 942 | 36,14 | 8,67 | 45 882 | 172 831 |
2015-02-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Option to Purchase Common Stock |
M - Exercise | X | −3 500 | 7 203 | −32,70 | |||
2015-02-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Option to Purchase Common Stock |
M - Exercise | X | −4 000 | 10 971 | −26,72 | |||
2015-02-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −953 | 14 648 | −6,11 | 208,10 | −198 317 | 3 048 208 |
2015-02-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 379 | 15 601 | −13,23 | 207,01 | −492 466 | 3 229 490 |
2015-02-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 068 | 17 980 | −5,61 | 206,03 | −220 041 | 3 704 437 |
2015-02-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −3 100 | 19 048 | −14,00 | 204,20 | −633 009 | 3 889 535 |
2015-02-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 3 500 | 22 148 | 18,77 | 10,40 | 36 400 | 230 341 |
2015-02-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 4 000 | 18 648 | 27,31 | 8,67 | 34 667 | 161 617 |
2015-01-07 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −664 | 14 648 | −4,34 | 172,63 | −114 627 | 2 528 702 |
2015-01-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −376 | 15 312 | −2,40 | 158,71 | −59 675 | 2 430 169 |
2015-01-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −1 623 | 6 490 | −20,00 | ||||
2015-01-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1 623 | 15 688 | 11,54 | ||||
2014-11-19 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | −4 000 | 10 703 | −27,21 | |||
2014-11-19 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −502 | 14 065 | −3,45 | 160,30 | −80 471 | 2 254 622 |
2014-11-19 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 698 | 14 567 | −10,44 | 159,62 | −271 038 | 2 325 214 |
2014-11-19 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 590 | 16 265 | −8,91 | 158,45 | −251 939 | 2 577 225 |
2014-11-19 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 000 | 17 855 | −5,30 | 157,28 | −157 282 | 2 808 279 |
2014-11-19 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 4 000 | 18 855 | 26,93 | 10,40 | 41 600 | 196 094 |
2014-10-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −832 | 14 855 | −5,30 | 233,97 | −194 664 | 3 475 639 |
2014-10-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | −4 000 | 14 703 | −21,39 | |||
2014-10-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −1 622 | 8 113 | −16,66 | ||||
2014-10-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −500 | 15 687 | −3,09 | 234,01 | −117 005 | 3 670 915 |
2014-10-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 000 | 16 187 | −5,82 | 232,96 | −232 965 | 3 771 004 |
2014-10-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 500 | 17 187 | −8,03 | 232,24 | −348 358 | 3 991 487 |
2014-10-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −688 | 18 687 | −3,55 | 227,69 | −156 651 | 4 254 843 |
2014-10-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −500 | 19 375 | −2,52 | 226,30 | −113 151 | 4 384 601 |
2014-10-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 4 000 | 19 875 | 25,20 | 10,40 | 41 600 | 206 702 |
2014-10-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1 622 | 15 875 | 11,38 | ||||
2014-09-17 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock |
M - Exercise | X | −4 000 | 18 703 | −17,62 | |||
2014-09-17 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 000 | 14 253 | −6,56 | 286,75 | −286 750 | 4 087 048 |
2014-09-17 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −3 000 | 15 253 | −16,44 | 279,33 | −838 001 | 4 260 678 |
2014-09-17 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 4 000 | 18 253 | 28,06 | 10,40 | 41 600 | 189 833 |
2014-08-29 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock |
M - Exercise | −10 000 | 30 131 | −24,92 | ||||
2014-08-29 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | −700 | 14 253 | −4,68 | 296,14 | −207 295 | 4 220 832 | |
2014-08-29 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | −1 200 | 14 953 | −7,43 | 295,61 | −354 732 | 4 420 255 | |
2014-08-29 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | −4 250 | 16 153 | −20,83 | 293,89 | −1 249 025 | 4 747 178 | |
2014-08-29 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | −3 850 | 20 403 | −15,87 | 293,05 | −1 128 233 | 5 979 048 | |
2014-08-29 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | 10 000 | 24 253 | 70,16 | 8,67 | 86 667 | 210 193 | |
2014-08-15 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock |
M - Exercise | X | −4 000 | 22 703 | −14,98 | |||
2014-08-15 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −4 000 | 14 253 | −21,91 | 292,16 | −1 168 656 | 4 164 215 |
2014-08-15 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −774 | 18 253 | −4,07 | 288,00 | −222 912 | 5 256 864 |
2014-08-15 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 4 000 | 19 027 | 26,62 | 10,40 | 41 600 | 197 883 |
2014-07-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −849 | 15 027 | −5,35 | 247,65 | −210 257 | 3 721 477 |
2014-07-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | −4 000 | 26 703 | −13,03 | |||
2014-07-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −1 623 | 9 735 | −14,29 | ||||
2014-07-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 000 | 15 876 | −5,93 | 246,00 | −246 000 | 3 905 496 |
2014-07-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 000 | 16 876 | −10,60 | 244,75 | −489 499 | 4 130 393 |
2014-07-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 187 | 18 876 | −5,92 | 241,53 | −286 696 | 4 559 120 |
2014-07-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 4 000 | 20 063 | 24,90 | 10,40 | 41 600 | 208 657 |
2014-07-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1 623 | 16 063 | 11,24 | ||||
2014-06-18 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Option to Purchase Common Stock |
M - Exercise | X | −4 000 | 30 703 | −11,53 | |||
2014-06-18 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 160 | 14 440 | −13,01 | 279,62 | −603 976 | 4 037 688 |
2014-06-18 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −840 | 16 600 | −4,82 | 278,55 | −233 982 | 4 623 930 |
2014-06-18 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 000 | 17 440 | −5,42 | 274,63 | −274 630 | 4 789 547 |
2014-06-18 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 4 000 | 18 440 | 27,70 | 10,40 | 41 600 | 191 778 |
2014-05-19 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Option to Purchase Common Stock |
M - Exercise | X | −4 000 | 34 703 | −10,34 | |||
2014-05-19 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 000 | 14 440 | −6,48 | 278,10 | −278 104 | 4 015 815 |
2014-05-19 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 000 | 15 440 | −11,47 | 277,00 | −554 000 | 4 276 880 |
2014-05-19 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 000 | 17 440 | −5,42 | 275,00 | −275 000 | 4 796 000 |
2014-05-19 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −743 | 18 440 | −3,87 | 272,00 | −202 096 | 5 015 680 |
2014-05-19 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 4 000 | 19 183 | 26,35 | 10,40 | 41 600 | 199 505 |
2014-04-15 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Option to Purchase Common Stock |
A - Award | 8 255 | 8 255 | |||||
2014-04-15 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Option to Purchase Common Stock |
A - Award | 1 835 | 1 835 | |||||
2014-04-15 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
A - Award | 1 504 | 15 183 | 10,99 | ||||
2014-04-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −879 | 13 679 | −6,04 | 321,95 | −282 997 | 4 403 994 |
2014-04-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock |
M - Exercise | X | −4 326 | 0 | −100,00 | |||
2014-04-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −1 622 | 11 358 | −12,50 | ||||
2014-04-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −500 | 14 558 | −3,32 | 338,16 | −169 082 | 4 922 977 |
2014-04-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −1 000 | 15 058 | −6,23 | 335,84 | −335 844 | 5 057 143 |
2014-04-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −388 | 16 058 | −2,36 | 334,52 | −129 793 | 5 371 690 |
2014-04-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −1 626 | 16 446 | −9,00 | 333,22 | −541 809 | 5 480 069 |
2014-04-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −1 000 | 18 072 | −5,24 | 330,06 | −330 060 | 5 964 844 |
2014-04-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 4 326 | 19 072 | 29,34 | 10,40 | 44 991 | 198 351 |
2014-04-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
M - Exercise | 1 622 | 14 746 | 12,36 | ||||
2014-03-19 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Option to sell Common Stock |
M - Exercise | −4 000 | 38 703 | −9,37 | ||||
2014-03-19 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Option to sell Common Stock |
M - Exercise | −4 917 | 42 703 | −10,33 | ||||
2014-03-19 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | −1 000 | 13 124 | −7,08 | 463,91 | −463 910 | 6 088 355 | |
2014-03-19 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | −1 000 | 14 124 | −6,61 | 444,25 | −444 246 | 6 274 523 | |
2014-03-19 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | −1 000 | 15 124 | −6,20 | 432,30 | −432 303 | 6 538 151 | |
2014-03-19 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | −258 | 16 124 | −1,57 | 422,05 | −108 888 | 6 805 071 | |
2014-03-19 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | −742 | 16 382 | −4,33 | 421,46 | −312 724 | 6 904 369 | |
2014-03-19 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | −456 | 17 124 | −2,59 | 410,92 | −187 379 | 7 036 586 | |
2014-03-19 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
M - Exercise | 4 000 | 17 580 | 29,46 | 10,40 | 41 600 | 182 834 | |
2014-03-19 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
M - Exercise | 4 917 | 13 580 | 56,76 | 10,40 | 51 137 | 141 233 | |
2014-02-18 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock |
M - Exercise | X | −4 327 | 4 326 | −50,01 | |||
2014-02-18 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −500 | 7 218 | −6,48 | 368,90 | −184 451 | 2 662 735 |
2014-02-18 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −2 400 | 7 718 | −23,72 | 368,02 | −883 246 | 2 840 371 |
2014-02-18 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −1 240 | 10 118 | −10,92 | 366,91 | −454 972 | 3 712 425 |
2014-02-18 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −1 632 | 11 358 | −12,56 | 365,37 | −596 279 | 4 149 836 |
2014-02-18 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 4 327 | 12 990 | 49,95 | 10,40 | 45 001 | 135 097 |
2014-01-10 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock |
M - Exercise | X | −3 800 | 50 719 | −6,97 | |||
2014-01-10 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock |
M - Exercise | X | −5 168 | 47 620 | −9,79 | |||
2014-01-10 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −928 | 8 663 | −9,68 | 73,09 | −67 826 | 633 161 |
2014-01-10 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −4 000 | 9 591 | −29,43 | 71,56 | −286 239 | 686 330 |
2014-01-10 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 3 800 | 13 591 | 38,81 | 8,67 | 32 933 | 117 789 |
2014-01-10 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 5 168 | 9 791 | 111,79 | 10,40 | 53 748 | 101 827 |
2014-01-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −1 623 | 12 980 | −11,11 | ||||
2014-01-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
M - Exercise | 1 623 | 4 623 | 54,10 | ||||
2013-12-17 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock |
M - Exercise | X | −3 750 | 52 788 | −6,63 | |||
2013-12-17 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −5 016 | 3 000 | −62,57 | 62,11 | −311 550 | 186 334 |
2013-12-17 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 3 750 | 8 016 | 87,90 | 10,40 | 39 000 | 83 367 |
2013-11-19 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock |
M - Exercise | X | −3 750 | 56 538 | −6,22 | |||
2013-11-19 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −4 730 | 4 266 | −52,58 | 48,08 | −227 412 | 205 104 |
2013-11-19 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 3 750 | 8 996 | 71,48 | 10,40 | 39 000 | 93 559 |
2013-10-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock |
M - Exercise | −3 750 | 60 288 | −5,86 | ||||
2013-10-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −642 | 5 246 | −10,90 | 73,10 | −46 930 | 383 481 |
2013-10-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −600 | 5 888 | −9,25 | 74,60 | −44 760 | 439 245 |
2013-10-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −1 177 | 6 488 | −15,36 | 73,02 | −85 943 | 473 745 |
2013-10-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −1 973 | 7 665 | −20,47 | 72,02 | −142 087 | 552 000 |
2013-10-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 3 750 | 9 638 | 63,69 | 10,40 | 39 000 | 100 236 |
2013-10-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −1 622 | 14 603 | −10,00 | ||||
2013-10-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
M - Exercise | 1 622 | 5 888 | 38,02 | ||||
2013-09-18 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock |
M - Exercise | X | −3 750 | 64 038 | −5,53 | |||
2013-09-18 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 3 750 | 9 282 | 67,79 | 10,40 | 39 000 | 96 534 |
2013-09-18 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −5 016 | 4 266 | −54,04 | 49,20 | −246 784 | 209 884 |
2013-08-16 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock |
M - Exercise | X | −3 750 | 67 788 | −5,24 | |||
2013-08-16 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −4 754 | 2 532 | −65,25 | 45,04 | −214 120 | 114 041 |
2013-08-16 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 3 750 | 7 286 | 106,05 | 10,40 | 39 000 | 75 775 |
2013-07-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock |
M - Exercise | X | −3 750 | 71 538 | −4,98 | |||
2013-07-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −4 369 | 3 536 | −55,27 | 43,63 | −190 623 | 154 278 |
2013-07-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 3 750 | 7 905 | 90,25 | 10,40 | 39 000 | 82 213 |
2013-07-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −1 623 | 16 225 | −9,09 | ||||
2013-07-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
M - Exercise | 1 623 | 4 155 | 64,10 | ||||
2013-06-19 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock |
M - Exercise | X | −3 750 | 75 288 | −4,74 | |||
2013-06-19 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −700 | 2 532 | −21,66 | 32,75 | −22 925 | 82 923 |
2013-06-19 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −3 316 | 3 232 | −50,64 | 32,75 | −108 599 | 105 848 |
2013-06-19 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 000 | 6 548 | −13,25 | 32,60 | −32 600 | 213 465 |
2013-06-19 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 3 750 | 7 548 | 98,74 | 10,40 | 39 000 | 78 500 |
2013-05-20 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock |
M - Exercise | X | −496 | 79 038 | −0,62 | |||
2013-05-20 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −100 | 3 798 | −2,57 | 31,30 | −3 130 | 118 877 |
2013-05-20 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −100 | 3 898 | −2,50 | 31,26 | −3 126 | 121 851 |
2013-05-20 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −662 | 3 998 | −14,21 | 31,22 | −20 668 | 124 818 |
2013-05-20 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −435 | 4 660 | −8,54 | 31,22 | −13 581 | 145 485 |
2013-05-20 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −465 | 5 095 | −8,36 | 31,20 | −14 508 | 158 964 |
2013-05-20 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 496 | 5 560 | 9,79 | 10,40 | 5 158 | 57 825 |
2013-05-20 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock |
M - Exercise | X | −3 254 | 79 534 | −3,93 | |||
2013-05-20 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −100 | 5 064 | −1,94 | 31,74 | −3 174 | 160 731 |
2013-05-20 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −300 | 5 164 | −5,49 | 31,70 | −9 509 | 163 675 |
2013-05-20 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −100 | 5 464 | −1,80 | 31,58 | −3 158 | 172 553 |
2013-05-20 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −100 | 5 564 | −1,77 | 31,56 | −3 156 | 175 600 |
2013-05-20 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −200 | 5 664 | −3,41 | 31,54 | −6 308 | 178 643 |
2013-05-20 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −80 | 5 864 | −1,35 | 31,50 | −2 520 | 184 716 |
2013-05-20 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −10 | 5 944 | −0,17 | 31,46 | −315 | 186 998 |
2013-05-20 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −100 | 5 954 | −1,65 | 31,40 | −3 140 | 186 950 |
2013-05-20 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −100 | 6 054 | −1,62 | 31,39 | −3 139 | 190 035 |
2013-05-20 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −100 | 6 154 | −1,60 | 31,37 | −3 137 | 193 051 |
2013-05-20 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −838 | 6 254 | −11,82 | 31,35 | −26 271 | 196 063 |
2013-05-20 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −120 | 7 092 | −1,66 | 31,29 | −3 754 | 221 885 |
2013-05-20 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −10 | 7 212 | −0,14 | 31,27 | −313 | 225 519 |
2013-05-20 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −90 | 7 222 | −1,23 | 31,23 | −2 811 | 225 531 |
2013-05-20 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −200 | 7 312 | −2,66 | 31,19 | −6 238 | 228 061 |
2013-05-20 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −100 | 7 512 | −1,31 | 31,14 | −3 114 | 233 924 |
2013-05-20 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −500 | 7 612 | −6,16 | 31,13 | −15 565 | 236 962 |
2013-05-20 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −90 | 8 112 | −1,10 | 31,12 | −2 801 | 252 475 |
2013-05-20 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −20 | 8 202 | −0,24 | 31,11 | −622 | 255 164 |
2013-05-20 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −30 | 8 222 | −0,36 | 30,99 | −930 | 254 800 |
2013-05-20 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −50 | 8 252 | −0,60 | 30,98 | −1 549 | 255 647 |
2013-05-20 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −16 | 8 302 | −0,19 | 30,70 | −491 | 254 871 |
2013-05-20 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 3 254 | 8 318 | 64,26 | 10,40 | 33 842 | 86 508 |
2013-05-09 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock |
A - Award | 22 500 | 22 500 | |||||
2013-05-09 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
A - Award | 3 000 | 8 064 | 59,24 | ||||
2013-04-11 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −8 113 | 17 848 | −31,25 | ||||
2013-04-11 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
F - Taxes | −3 049 | 5 064 | −37,58 | 34,57 | −105 404 | 175 062 | |
2013-04-11 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
M - Exercise | 8 113 | 8 113 | |||||
2013-04-11 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −2 100 | 0 | −100,00 | 34,50 | −72 450 | |
2013-04-11 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −100 | 2 100 | −4,55 | 34,38 | −3 438 | 72 198 |
2013-04-11 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −200 | 2 200 | −8,33 | 34,38 | −6 875 | 75 625 |
2013-04-11 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −200 | 2 400 | −7,69 | 34,35 | −6 870 | 82 440 |
2013-04-11 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −100 | 2 600 | −3,70 | 34,33 | −3 433 | 89 250 |
2013-04-11 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −100 | 2 700 | −3,57 | 34,32 | −3 432 | 92 664 |
2013-04-11 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −300 | 2 800 | −9,68 | 34,31 | −10 293 | 96 068 |
2013-04-11 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −300 | 3 100 | −8,82 | 34,30 | −10 290 | 106 330 |
2013-04-11 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −100 | 3 400 | −2,86 | 34,29 | −3 429 | 116 586 |
2013-04-11 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −200 | 3 500 | −5,41 | 34,25 | −6 850 | 119 875 |
2013-04-11 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −50 | 3 700 | −1,33 | 33,86 | −1 693 | 125 282 |
2013-04-11 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 3 750 | 3 750 | 10,40 | 39 000 | 39 000 | |
2013-04-11 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock |
M - Exercise | X | −3 750 | 82 788 | −4,33 | |||
2012-11-20 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock |
A - Award | 17 307 | 17 307 | |||||
2012-11-20 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Restricted Stock Units |
A - Award | 25 961 | 25 961 |